A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole.
J Travel Med
; 10(2): 128-30, 2003.
Article
en En
| MEDLINE
| ID: mdl-12650658
ABSTRACT
Blastocystis hominis, previously considered a harmless yeast, is now classified as a protozoan inhabiting the human intestinal tract. The pathogenicity of B. hominis remains controversial and is currently the subject of extensive debate.1- 5 As a result of the uncertainty surrounding the pathogenic role of B. hominis, large-scale treatment trials of B. hominis infection have so far been lacking. In spite of this, several drugs have been reported to be active against the parasite.6-8 The present study was carried out in order to evaluate the efficacy of metronidazole treatment in inducing clinical remission and parasitologic eradication in immunocompetent individuals with B. hominis as the only evident cause of diarrhea.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Infecciones por Blastocystis
/
Blastocystis hominis
/
Diarrea
/
Metronidazol
/
Antiprotozoarios
Tipo de estudio:
Clinical_trials
/
Etiology_studies
Límite:
Animals
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Europa
Idioma:
En
Revista:
J Travel Med
Asunto de la revista:
DOENCAS TRANSMISSIVEIS
/
SAUDE PUBLICA
Año:
2003
Tipo del documento:
Article
País de afiliación:
Italia